These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30792900)

  • 1. Molecular yield of targeted sequencing for Glanzmann thrombasthenia patients.
    Owaidah T; Saleh M; Baz B; Abdulaziz B; Alzahrani H; Tarawah A; Almusa A; AlNounou R; AbaAlkhail H; Al-Numair N; Altahan R; Abouelhoda M; Alamoudi T; Monies D; Jabaan A; Al Tassan N
    NPJ Genom Med; 2019; 4():4. PubMed ID: 30792900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Sequencing Based Approach to Identify Underlying Genetic Defects of Glanzmann Thrombasthenia.
    Sharma R; Jamwal M; Senee HK; Uppal V; Hira JK; Bose P; Kumar N; Bansal D; Trehan A; Malhotra P; Ahluwalia J; Das R
    Indian J Hematol Blood Transfus; 2021 Jul; 37(3):414-421. PubMed ID: 34267460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage disequilibrium amongst ITGA2B and ITGB3 gene variants in patients with Glanzmann thrombasthenia confirms that most disease-causing mutations are recent.
    Pillois X; Nurden AT
    Br J Haematol; 2016 Nov; 175(4):686-695. PubMed ID: 27469266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations.
    Sandrock-Lang K; Oldenburg J; Wiegering V; Halimeh S; Santoso S; Kurnik K; Fischer L; Tsakiris DA; Sigl-Kraetzig M; Brand B; Bührlen M; Kraetzer K; Deeg N; Hund M; Busse E; Kahle A; Zieger B
    Thromb Haemost; 2015 Apr; 113(4):782-91. PubMed ID: 25373348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
    Nurden AT; Pillois X; Fiore M; Alessi MC; Bonduel M; Dreyfus M; Goudemand J; Gruel Y; Benabdallah-Guerida S; Latger-Cannard V; Négrier C; Nugent D; Oiron RD; Rand ML; Sié P; Trossaert M; Alberio L; Martins N; Sirvain-Trukniewicz P; Couloux A; Canault M; Fronthroth JP; Fretigny M; Nurden P; Heilig R; Vinciguerra C
    Hum Mutat; 2015 May; 36(5):548-61. PubMed ID: 25728920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations of integrin αIIb and β3 genes in Turkish children with Glanzmann's thrombasthenia.
    Tokgoz H; Torun Ozkan D; Caliskan U; Akar N
    Platelets; 2015; 26(8):779-82. PubMed ID: 25734216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Confirmation and Identification of Novel Variants for Glanzmann Thrombasthenia and Other Inherited Platelet Function Disorders: A Study by the Korean Pediatric Hematology Oncology Group (KPHOG).
    Yang EJ; Shim YJ; Kim HS; Lim YT; Im HJ; Koh KN; Kim H; Suh JK; Park ES; Lee NH; Choi YB; Hah JO; Lee JM; Han JW; Lee JH; Lee YH; Jung HL; Ha JS; Ki CS; On Behalf Of The Benign Hematology Committee Of The Korean Pediatric Hematology Oncology Group Kphog
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34066320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel and recurrent mutations of ITGA2B and ITGB3 genes in Korean patients with Glanzmann thrombasthenia.
    Park KJ; Chung HS; Lee KO; Park IA; Kim SH; Kim HJ
    Pediatr Blood Cancer; 2012 Aug; 59(2):335-8. PubMed ID: 22190468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic diagnosis of Tunisian Glanzmann thrombasthenia patients reveals a common nonsense mutation in the ITGA2B gene that seems to be specific for the studied population.
    Aloui C; Chakroun T; Granados V; Jemni-Yacoub S; Fagan J; Khelif A; Kahloul N; Hammami S; Chkioua L; Barlier C; Cognasse F; Laradi S; Garraud O
    Blood Coagul Fibrinolysis; 2018 Dec; 29(8):689-696. PubMed ID: 30325339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous point mutations in platelet glycoprotein ITGA2B gene as cause of Glanzmann thrombasthenia in 2 families.
    Sandrock K; Halimeh S; Wiegering V; Kappert G; Sauer K; Deeg N; Busse E; Zieger B
    Klin Padiatr; 2012 Apr; 224(3):174-8. PubMed ID: 22513797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel homozygous silent mutation of
    Wang Z; Xu Y; Sun Y; Wang S; Dong M
    Front Pediatr; 2022; 10():1062900. PubMed ID: 36704147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic diagnosis of Glanzmann syndrome in Iranian population; reporting novel and recurrent mutations.
    Zafarghandi Motlagh F; Fallah MS; Bagherian H; Shirzadeh T; Ghasri S; Dabbagh S; Jamali M; Salehi Z; Abiri M; Zeinali S
    Orphanet J Rare Dis; 2019 Apr; 14(1):87. PubMed ID: 31029159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression, and structure-function.
    Jallu V; Dusseaux M; Panzer S; Torchet MF; Hezard N; Goudemand J; de Brevern AG; Kaplan C
    Hum Mutat; 2010 Mar; 31(3):237-46. PubMed ID: 20020534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glanzmann thrombasthenia in Pakistan: molecular analysis and identification of novel mutations.
    Haghighi A; Borhany M; Ghazi A; Edwards N; Tabaksert A; Haghighi A; Fatima N; Shamsi TS; Sayer JA
    Clin Genet; 2016 Feb; 89(2):187-92. PubMed ID: 26096001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular analysis of gene mutations in eight patients with Glanzmann's thrombasthenia].
    Miao LZ; Gan FY; Gong Y; Qu CX; Wang JZ; Yuan JY; Gao BJ; Lu Y; You R
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2418-2423. PubMed ID: 30138987
    [No Abstract]   [Full Text] [Related]  

  • 16. Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies.
    Mathews N; Rivard GE; Bonnefoy A
    J Blood Med; 2021; 12():449-463. PubMed ID: 34149292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the platelet proteome in type I Glanzmann thrombasthenia caused by different homozygous delG frameshift mutations in ITGA2B.
    Loroch S; Trabold K; Gambaryan S; Reiß C; Schwierczek K; Fleming I; Sickmann A; Behnisch W; Zieger B; Zahedi RP; Walter U; Jurk K
    Thromb Haemost; 2017 Feb; 117(3):556-569. PubMed ID: 28078347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?
    Nurden A
    J Blood Med; 2021; 12():581-599. PubMed ID: 34267570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glanzmann Thrombasthenia 10 Years Later: Progress Made and Future Directions.
    Nurden AT; Nurden P
    Semin Thromb Hemost; 2024 Mar; ():. PubMed ID: 38499192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of one novel pathogenic
    Lu Z; Nikuze L; Zhong Z; Li F; Zhang F; Liang K; Wei M; Wei H
    Platelets; 2020; 31(3):355-359. PubMed ID: 31088191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.